Lazard Asset Management
SWAV

Lazard Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Lazard Asset Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,911
Closed -$7.46M – 2475
2024
Q1 		$7.46M Sell
22,911
-6,557
-22% -$1.61M 0.01% 604
2023
Q4 		$5.61M Buy
29,468
+2,654
+10% +$502K 0.01% 660
2023
Q3 		$5.34M Buy
26,814
+7,886
+42% +$1.87M 0.01% 683
2023
Q2 		$5.4M Buy
18,928
+284
+2% +$78.9K 0.01% 693
2023
Q1 		$4.04M Buy
18,644
+15,168
+436% +$2.96M 0.01% 772
2022
Q4 		$714K Buy
3,476
+40
+1% +$10.1K ﹤0.01% 1055
2022
Q3 		$954K Buy
3,436
+2,380
+225% +$605K ﹤0.01% 992
2022
Q2 		$201K Sell
1,056
-3,756
-78% -$663K ﹤0.01% 1283
2022
Q1 		$997K Buy
4,812
+2,459
+105% +$405K ﹤0.01% 999
2021
Q4 		$418K Buy
2,353
+41
+2% +$8.09K ﹤0.01% 1133
2021
Q3 		$475K Buy
+2,312
New +$454K ﹤0.01% 1185

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Lazard Asset Management's SWAV Position: Q2 2024 in Review

Lazard Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 22,911 shares — an estimated $7.46M sold.

Lazard Asset Management first reported a position in SWAV in Q3 2021 and held it in 11 quarters. The position peaked at $7.46M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Lazard Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Lazard Asset Management sold 22,911 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.46M.
  • Lazard Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Lazard Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $7.46M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.